Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines
Phase IV Clinical Trial to Assess the Safety, Immunogenicity,Three-year Immune Persistence of Inactivated Hepatitis A Vaccine (HAV) and Live Attenuated HAV Vaccine in Health Chinese Children and Adult
Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences
A PHASE4 clinical study on Hepatitis A, this trial is completed. The trial is conducted by Institute of Medical Biology, Chinese Academy of Medical Sciences and has accumulated 7 data snapshots since 2011. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Oct 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Oct 2023 [monthly]
Completed PHASE4
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE4
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Nov 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institute of Medical Biology, Chinese Academy of Medical Sciences
- Jiangsu Province Centers for Disease Control and Prevention
For direct contact, visit the study record on ClinicalTrials.gov .